Recent Updates
Recently added Catalysts
VKTX Positive Sentiment

Karen C. Chung, PharmD, MS

Friday, January 9, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Karen C. Chung, PharmD, MS, has been appointed Vice President of Medical Affairs at Viking Therapeutics. With over 25 years of experience in the pharmaceutical and biotechnology sectors, she has held significant roles at GRAIL, Inc. and Juno Therapeutics. Dr. Chung's expertise spans product launches and lifecycle management across multiple therapeutic areas.
Price reaction · baseline $32.1523 (2026-01-09T16:32:00.000Z) · hit during market hours · 4 other VKTX headline(s) in the window, move may be shared
day 0 close · peak
-0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Chung has over 25 years of experience in the industry.
  • She has a strong background in health economics and outcomes research.
  • Her experience includes launching products across various therapeutic areas.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss

Full Press Release Details

Karen Chung serves as our Vice President, Medical Affairs. Dr. Chung has over 25 years in the pharmaceutical and biotechnology industry. Prior to joining Viking, Dr. Chung was Head of Health Economics and Outcomes Research at GRAIL, Inc. and Juno Therapeutics (acquired by Celgene). Experience also includes both launching products as well as product lifecycle management across therapeutic areas, including Jazz Pharmaceuticals (Vyxeos), Gilead Sciences (antiretrovirals), Amgen (oncology), Baxter BioSciences (plasma-based products), and Bayer Pharmaceuticals (cardiovascular and oncology). Dr. Chung earned her PharmD from the University of Southern California and her Master’s Degree in Health Economics at The University of Arizona.

Frequently Asked Questions

What is Karen C. Chung's role at Viking Therapeutics?

Karen C. Chung serves as the Vice President of Medical Affairs.

How many years of experience does Dr. Chung have?

Dr. Chung has over 25 years of experience in the pharmaceutical and biotechnology industry.

Where did Dr. Chung earn her PharmD?

She earned her PharmD from the University of Southern California.

What companies did Dr. Chung work for before Viking?

She worked at GRAIL, Inc., Juno Therapeutics, Jazz Pharmaceuticals, and others.

ShareAdd on Google
Tags: VKTX Viatris Investor Conferences Healthcare Viking Therapeutics Karen C. Chung medical affairs biotechnology pharmaceuticals
Last updated: Jan 9, 2026

Biotech snapshot

Cash runway
$502M liquidity · $42M/mo burn
~11 mo
Medium dilution risk
Lead asset
VK2735Phase 3
Weight Loss →

Catalyst track record

+53%
best trade around VKTX's most recent catalyst

Peak hindsight return over a 120-day window, across 5 tracked FDA/PDUFA catalysts for VKTX.

See every catalyst's timing & PoA →